ClinicalTrials.Veeva

Menu

Device-based QRS Evaluation

Abbott logo

Abbott

Status

Completed

Conditions

Heart Failure

Treatments

Device: ECG+IEGM

Study type

Observational

Funder types

Industry

Identifiers

NCT02814214
CRD_865

Details and patient eligibility

About

The purpose of this study is to collect simultaneous surface electrocardiogram (ECG) recordings and Cardiac Resynchronization Therapy (CRT) intracardiac electrogram (IEGM) recordings of variations in electrical synchrony.

Enrollment

103 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Already implanted with SJM Quadripolar CRT Pacing System
  • Ability to provide informed consent for study participation
  • Willing to comply with the study evaluation requirements
  • At least 18 years of age

Exclusion criteria

  • Resting ventricular rate >100 bpm
  • Intrinsic PR interval > 300 ms
  • Paroxysmal or persistent atrial tachycardia or atrial fibrillation documented
  • Pregnant or plans to become pregnant during the study

Trial design

103 participants in 1 patient group

ECG+IEGM
Description:
Surface ECG and intracardiac electrogram recordings will be taken during the adjustment of programmable Cardiac Resynchronization Therapy settings
Treatment:
Device: ECG+IEGM

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems